| Literature DB >> 35087373 |
Jing Wang1, Pengfei Ke2,3, Jinyu Zang2,3, Fengchun Wu4,5, Kai Wu2,4,5,6,3,7,8,9.
Abstract
Interest in the application of machine learning (ML) techniques to multimodal magnetic resonance imaging (MRI) data for the diagnosis of schizophrenia (SZ) at the individual level is growing. However, a few studies have applied the features of structural and functional brain networks derived from multimodal MRI data to the discriminative analysis of SZ patients at different clinical stages. In this study, 205 normal controls (NCs), 61 first-episode drug-naive SZ (FESZ) patients, and 79 chronic SZ (CSZ) patients were recruited. We acquired their structural MRI, diffusion tensor imaging, and resting-state functional MRI data and constructed brain networks for each participant, including the gray matter network (GMN), white matter network (WMN), and functional brain network (FBN). We then calculated 3 nodal properties for each brain network, including degree centrality, nodal efficiency, and betweenness centrality. Two classifications (SZ vs. NC and FESZ vs. CSZ) were performed using five ML algorithms. We found that the SVM classifier with the input features of the combination of nodal properties of both the GMN and FBN achieved the best performance to discriminate SZ patients from NCs [accuracy, 81.2%; area under the receiver operating characteristic curve (AUC), 85.2%; p < 0.05]. Moreover, the SVM classifier with the input features of the combination of the nodal properties of both the GMN and WMN achieved the best performance to discriminate FESZ from CSZ patients (accuracy, 86.2%; AUC, 92.3%; p < 0.05). Furthermore, the brain areas in the subcortical/cerebellum network and the frontoparietal network showed significant importance in both classifications. Together, our findings provide new insights to understand the neuropathology of SZ and further highlight the potential advantages of multimodal network properties for identifying SZ patients at different clinical stages.Entities:
Keywords: brain networks; discriminative analysis; machine learning; multimodal MRI; schizophrenia
Year: 2022 PMID: 35087373 PMCID: PMC8787107 DOI: 10.3389/fnins.2021.785595
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
FIGURE 1Flowchart of the ML classification method.
FIGURE 2Definition of eight functional networks using a 268-node functional atlas. The figure was generated by using the toolbox BrainNet Viewer (http://www.nitrc.org/projects/bnv/).
Demographic and clinical characteristics.
| FESZ patients | CSZ patients | NC | Statistic value | ||
| Sex (F:M) | 41:20 | 54:25 | 110:95 | χ2 = 3.53 | 0.03 |
| Age (years) | 32.08 ± 7.42 | 33.21 ± 8.37 | 32.52 ± 8.40 | <0.05 | |
| Education (years) | 10.39 ± 3.25 | 11.97 ± 3.22 | 12.84 ± 2.83 | <0.05 | |
| PANSS-PScore | 24.02 ± 4.50 | 22.47 ± 5.70 | – | 0.083 | |
| PANSS-NScore | 21.64 ± 7.70 | 23.22 ± 7.29 | – | 0.218 | |
| PANSS-GScore | 40.31 ± 8.85 | 39.54 ± 10.18 | – | 0.641 | |
| PANSS-TScore | 85.97 ± 17.49 | 85.23 ± 19.44 | – | 0.816 |
Values are represented as the mean ± standard deviation (SD). The comparisons of age and education among the three groups (FESZ, NC, and CSZ) were performed using a separate one-way ANOVA. Post hoc pairwise comparisons were then performed using a two-sample t-test. Statistical significance was set at p < 0.05. For the sex distribution among the three groups, the p value was obtained using the χ2 test.
CSZ, chronic schizophrenia; F, female; FESZ, first-episode drug-naive schizophrenia; GScore, general score; M, male; NC, normal control; NScore, negative syndrome score; PANSS, Positive and Negative Syndrome Scale; PScore, positive syndrome score; TScore, total syndrome score.
FIGURE 3Accuracy values of the classifications between SZ patients and NCs based on five ML methods. *The star indicates the highest values of best performance of the classifications between SZ patients and NCs.
FIGURE 4Subnetwork distribution of ROIs from the FBN and GMN in the best classification between SZ patients and NCs.
FIGURE 5Accuracy values of the classifications between FESZ and CSZ patients based on five ML methods. *The star indicates the highest values of best performance of the classifications between FESZ and CSZ patients.
FIGURE 6Subnetwork distribution of ROIs from the GMN and WMN in the best classification between FESZ and CSZ patients.